scholarly journals Targeting Concentric Left Ventricular Hypertrophy in Obstructive Sleep Apnea Syndrome. A Meta-analysis of Echocardiographic Studies

2019 ◽  
Vol 33 (4) ◽  
pp. 310-315 ◽  
Author(s):  
Cesare Cuspidi ◽  
Marijana Tadic ◽  
Carla Sala ◽  
Elisa Gherbesi ◽  
Guido Grassi ◽  
...  

Abstract Aim We assessed the association between obstructive sleep apnea (OSA) and left ventricular hypertrophy (LVH) subtypes (i.e., concentric and eccentric LVH) trough a meta-analysis of echocardiographic studies. Design The PubMed, OVID-MEDLINE, and Cochrane library databases were systematically analyzed to search full papers published from 1st January 2000 to 31st August 2019. Studies were detected by using the following terms: “obstructive sleep apnea”, “sleep disordered breathing”, “left ventricular mass”, “left ventricular geometry”, “left ventricular hypertrophy”, “echocardiography”. Results Meta-analysis included 1,760 patients with OSA and 1,284 non-OSA controls from 9 studies. The prevalence rates of concentric and eccentric LVH in the pooled OSA population were 24.0% (confidence interval [CI] 16.0–33.0%) and 16.0% (CI 12.0–23.0%), respectively. Meta-analysis of six studies comparing the prevalence of LVH subtypes in participants with OSA and controls showed that OSA was associated with an increased risk of both concentric (odds ratio [OR] = 1.62, CI: 1.27–2.07, P < 0.0001) and eccentric (OR = 1.34, CI: 1.07–1.67, P < 0.009) LVH, respectively. Conclusions Our findings suggest that in the OSA setting concentric LVH is more frequent than eccentric LVH. From a practical perspective, in consideration of the particularly adverse prognostic significance of concentric LVH, a comprehensive echocardiographic evaluation targeting LVH subtypes could improve cardiovascular risk stratification in patients with OSA.

CHEST Journal ◽  
2006 ◽  
Vol 130 (4) ◽  
pp. 93S
Author(s):  
Rishi Sukhija ◽  
Wilbert S. Aronow ◽  
Rasham Sandhu ◽  
Priyanka Kakar ◽  
George P. Maguire ◽  
...  

2019 ◽  
Vol 8 (10) ◽  
pp. 1671 ◽  
Author(s):  
Beata Krasińska ◽  
Szczepan Cofta ◽  
Ludwina Szczepaniak-Chicheł ◽  
Piotr Rzymski ◽  
Tomasz Trafas ◽  
...  

The obstructive sleep apnea (OSA) is highly associated with various significant cardiovascular outcomes such as resistant hypertension (RAH). Despite this, as of now the relationship between high night-time blood pressure (BP) and left ventricular hypertrophy (LVH) in patients with OSA and RAH is not fully understood. The aim of this study was to assess the influence of the addition of eplerenone to a standard antihypertensive therapy on parameters of 24-h ambulatory blood pressure measurement (ABPM) as well as on the results of echocardiography and polysomnography in patients with OSA and RAH. The patients were randomly assigned to one of the two study groups: the treatment group, receiving 50 mg/d eplerenone orally for 6 months (n = 51) and the control group, remaining on their standard antihypertensive therapy (n = 51). After that period, a significant reduction in the night-time BP parameters in the treatment group including an increased night blood pressure fall from 4.6 to 8.9% was noted. Additionally, the number of non-dipper patients was reduced by 45.1%. The treatment group also revealed a decrease in left ventricular hypertrophy and in the apnea–hypopnea index (AHI) with a positive correlation being observed between these two parameters. This study is the first to report the improvement of the circadian BP profile and the improvement of the left ventricle geometry in patients with OSA and RAH following the addition of selective mineralocorticoid receptor antagonists to antihypertensive therapy.


2006 ◽  
Vol 14 (4) ◽  
pp. 170-172 ◽  
Author(s):  
Rishi Sukhija ◽  
Wilbert S. Aronow ◽  
Rasham Sandhu ◽  
Priyanka Kakar ◽  
George P. Maguire ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document